摘要
目的观察中药复方治疗轻度认知损害(MCI)的效果。方法选取100例MCI患者,按随机数字表法分为治疗组和对照组,各50例。治疗组予中药复方治疗,对照组予安慰剂治疗,疗程均为12周,比较治疗效果。用药前后记录蒙特利尔认知评价量表(Mo CA),日常生活能力(ADL)评分。结果治疗组Mo CA评分显著升高(P <0.05),对照组评分显著降低(P <0.05),2组比较差异有统计学意义(P <0.05)。ADL评分治疗组与对照组无明显差异(P> 0.05)。结论中药复方治疗MCI有一定的效果,且安全性较好。
Objective To observe the effect of traditional Chinese medicine compound on mild cognitive impairment (MCI). Methods 100 MCI patients were randomly divided into treatment group and control group according to the digital grouping, 50 in each group. The treatment group was treated with Chinese medicine compound, and the control group was treated with placebo. Both groups were treated for 12 weeks. The scores of MoCA and ADL were recorded before and after treatment. Results MoCA scores in the treatment group were significantly increased (P<0.05), while those in the control group were significantly decreased (P<0.05). The difference between the two groups was statistically significant (P<0.05). There was no significant difference in ADL score between the treatment group and the control group (P>0.05). Conclusion The Chinese medicine compound is effective and safe in treating mild cognitive impairment.
作者
王晶
刘丹
陈民
WANG Jing;LIU Dan;CHEN Min(Affiliated Hospital of Liaoning University of Traditional Chinese Medicine,Shenyang 110032,China;Changchun Hospital of Traditional Chinese Medicine,Changchun 130022,China)
出处
《长春中医药大学学报》
2019年第1期62-63,66,共3页
Journal of Changchun University of Chinese Medicine
基金
沈阳市科技局项目"基于载脂蛋白E基因多态性及血清Aβ1-40水平对认知功能损害患者的随访研究"(F16-206-9-24)
国家中医药管理局十二五重点学科项目(2012-32)
国家中医药管理局"全国名老中医药专家李敬林传承工作室"(201606)
关键词
轻度认知损害
中药复方
疗效观察
mild cognitive impairment
Chinese medicine compound
curative effect observation